MDAI vs. EXEL
MDAI (Spectral AI Inc.) and EXEL (Exelixis, Inc.) are both stocks. Both are in the Healthcare sector — MDAI in Medical Devices, EXEL in Biotechnology. Over the past 5 years, MDAI returned -29.33%/yr vs 17.56%/yr for EXEL. At a 0.07 correlation, their price movements are largely independent.
Performance
MDAI vs. EXEL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MDAI achieves a 20.42% return, which is significantly higher than EXEL's 17.13% return.
MDAI
- 1D
- -1.16%
- 1M
- -36.19%
- YTD
- 20.42%
- 6M
- 17.93%
- 1Y
- -16.59%
- 3Y*
- -45.30%
- 5Y*
- -29.33%
- 10Y*
- —
EXEL
- 1D
- -0.02%
- 1M
- 2.37%
- YTD
- 17.13%
- 6M
- 10.15%
- 1Y
- 18.38%
- 3Y*
- 37.24%
- 5Y*
- 17.56%
- 10Y*
- 20.91%
MDAI vs. EXEL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
MDAI Spectral AI Inc. | 20.42% | -49.82% | 15.04% | -75.64% | 2.96% | 1.55% |
EXEL Exelixis, Inc. | 17.13% | 31.62% | 38.81% | 49.56% | -12.25% | -22.15% |
Correlation
The correlation between MDAI and EXEL is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Apr 6, 2021 | 0.07 |
Fundamentals
MDAI:
$54.30M
EXEL:
$13.72B
MDAI:
-$0.50
EXEL:
$3.00
MDAI:
2.92
EXEL:
6.01
MDAI:
$16.70M
EXEL:
$2.38B
MDAI:
$7.47M
EXEL:
$1.70B
MDAI:
-$10.62M
EXEL:
$991.79M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MDAI vs. EXEL — Risk / Return Rank
MDAI
EXEL
MDAI vs. EXEL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Spectral AI Inc. (MDAI) and Exelixis, Inc. (EXEL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MDAI | EXEL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.69 | ||
| Sortino ratioReturn per unit of downside risk | -0.67 | ||
| Omega ratioGain probability vs. loss probability | 1.02 | 1.13 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | -0.27 | 0.73 | -1.00 |
| Martin ratioReturn relative to average drawdown | -0.41 | 1.77 | -2.18 |
Loading charts...
Drawdowns
MDAI vs. EXEL - Drawdown Comparison
The maximum MDAI drawdown since its inception was -93.49%, roughly equal to the maximum EXEL drawdown of -97.38%. Use the drawdown chart below to compare losses from any high point for MDAI and EXEL.
Loading charts...
Drawdown Indicators
| MDAI | EXEL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.49% | -97.38% | +3.89% |
Max Drawdown (1Y)Largest decline over 1 year | -61.78% | -25.16% | -36.62% |
Max Drawdown (3Y)Largest decline over 3 years | -93.49% | -25.34% | -68.15% |
Max Drawdown (5Y)Largest decline over 5 years | -93.49% | -36.12% | -57.37% |
Max Drawdown (10Y)Largest decline over 10 years | — | -57.20% | — |
Current DrawdownCurrent decline from peak | -88.15% | -4.04% | -84.11% |
Average DrawdownAverage peak-to-trough decline | -48.33% | -70.96% | +22.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 40.23% | 10.42% | +29.81% |
Volatility
MDAI vs. EXEL - Volatility Comparison
Spectral AI Inc. (MDAI) has a higher volatility of 18.55% compared to Exelixis, Inc. (EXEL) at 9.38%. This indicates that MDAI's price experiences larger fluctuations and is considered to be riskier than EXEL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MDAI | EXEL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.55% | 9.38% | +9.17% |
Volatility (6M)Calculated over the trailing 6-month period | 51.15% | 25.53% | +25.62% |
Volatility (1Y)Calculated over the trailing 1-year period | 74.76% | 40.28% | +34.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 82.60% | 37.17% | +45.43% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 80.83% | 44.48% | +36.35% |
Dividends
MDAI vs. EXEL - Dividend Comparison
Neither MDAI nor EXEL has paid dividends to shareholders.
Financials
MDAI vs. EXEL - Financials Comparison
This section allows you to compare key financial metrics between Spectral AI Inc. and Exelixis, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MDAI vs. EXEL - Profitability Comparison
MDAI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Spectral AI Inc. reported a gross profit of 2.03M and revenue of 3.99M. Therefore, the gross margin over that period was 50.8%.
EXEL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Exelixis, Inc. reported a gross profit of 0.00 and revenue of 610.81M. Therefore, the gross margin over that period was 0.0%.
MDAI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Spectral AI Inc. reported an operating income of -1.97M and revenue of 3.99M, resulting in an operating margin of -49.4%.
EXEL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Exelixis, Inc. reported an operating income of 251.34M and revenue of 610.81M, resulting in an operating margin of 41.2%.
MDAI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Spectral AI Inc. reported a net income of -3.41M and revenue of 3.99M, resulting in a net margin of -85.5%.
EXEL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Exelixis, Inc. reported a net income of 210.47M and revenue of 610.81M, resulting in a net margin of 34.5%.
Frequently Asked Questions
MDAI and EXEL have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MDAI has higher volatility (18.55%) compared to EXEL (9.38%). In terms of maximum drawdown, MDAI dropped -93.49% vs EXEL's -97.38%.
EXEL currently has the higher Sharpe Ratio (0.47 vs -0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MDAI and EXEL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer